For three consecutive years, the adverse analytical finding (AAF) rate published by the World Anti-Doping Agency has sat at 0.77%, 0.80% and 0.78%. The figure has barely moved across an entire reporting cycle. For someone who works with data, that stability is more interesting than any headline.

The 2026 testing total was 297,965 samples, roughly 9,100 more than the 288,865 collected in 2026. In absolute terms, this is the highest point in the seven-year series running from 2026. But look at the derivative — the rate of change — and the picture flips: growth from 2026 to 2026 was 12.5%, while growth from 2026 to 2026 fell to 3.2%. The curve is flattening, not steepening.

I open with those two numbers because they tell a story the headline does not. And for swimming — a sport that depends on dense testing both in and out of competition — that story matters more than most people assume.

WADA's 2026 annual report is a governance document, quite unlike a sports news item. There is no lane, no technique, no named athlete in it. What it provides is the operational data set of the global anti-doping system: sample volumes, positivity rates, compliance audit results, finances, and the reform timeline for the rules.

The data structure is fairly consistent: a testing series from 2026 to 2026, with annual sample totals published year by year. The AAF rate — the share of samples returning a prohibited substance or method — moved within a very narrow band, roughly plus or minus 0.03 percentage points, across the last three years. This is the kind of data that supports long-series comparison, quite unlike subjective assessments.

On compliance, WADA ran nine audits, and the average number of non-conformities fell from 25.5 to 20. That is the good-news section the report wants to highlight. But deeper inside, one specific category moves the other way: testing-related non-conformities rose 11%, accounted for 45% of all findings, and 23% of those were classified as critical.

For swimming, the relevance lies in the sport's reliance on out-of-competition testing. A swimmer can be called for a test at any time, anywhere. If sample collection weakens at the national federation level, the gap does not open in the big stadiums — it opens in smaller nations, where pools draw little attention but still produce Olympic athletes.

The financial picture complicates everything. WADA fell 8.3 million USD short of its projected budget. The United States has not paid 3.8 million USD; Russia owes 3.9 million USD. The only counterweight is a recorded net surplus of 1.2 million USD.

At this point I need to separate the zone of established data from the zone of inference.

The established zone has three layers. The first is volume: 288,865 samples in 2026, 297,965 in 2026, a difference of 9,100. The second is pace: 12.5% then 3.2% — growth is decelerating. The third is detection: 0.77%, then 0.80%, then 0.78% — essentially flat.

Stack those three layers and a small paradox appears. If testing volume rises while the positivity rate holds steady, there are two explanations. One is that underlying doping prevalence in the athlete population is stable, and expanded testing simply reaches a group with the same positivity. The other is that the system now tests more intelligently, targets better, and therefore raises volume without raising the detection rate.

The report's data set does not let me separate these hypotheses. And that is exactly where I have to be blunt: a stable 0.78% does not mean everything is clean, and it does not mean doping is getting worse. It only means input rose while output held — an ambiguous signal on efficiency, but a clear one on resources.

The fourth layer, compliance, is where the concern sits. Nine audits is far too small a sample to say anything about a global trend. When I see the drop from 25.5 to 20 presented as progress, I immediately recall a familiar lesson in statistics: small samples generate large swings that get mistaken for trends. With n equals 9, confidence is low enough that the number cannot support any claim about the health of the system.

By contrast, the 45% share within testing non-conformities — alongside the 11% rise and the 23% critical classification — is far more concrete, because it belongs to a single functional category. When errors concentrate in one part of the process, that usually signals a systemic problem, rarely just a handful of isolated incidents.

In parallel, WADA is pushing a new approach: shifting from traditional testing toward investigations and prevention. More than 250 investigative operations, 88 laboratories dismantled, over 90 tonnes seized. That shift changes how resources are allocated across the whole system, and every swimming federation sits inside its reach, whether it likes it or not.

On consultation, WADA worked with the Athlete Council on an athlete-centred process involving more than 600 athletes and commissions from over 60 countries and more than 70 sports. That signals a legitimacy-building effort. But the report does not say whether athlete input actually changed the substance of the Code, and I place that in the ambiguous zone.

The final anchor is the 2027 World Anti-Doping Code, adopted in Busan, South Korea, effective January 1, 2027. This is a fixed date with high planning value for any federation.

The headline about expanded testing reads like a statement about momentum. The data says otherwise. Growth is slowing, the detection rate is flat, and the 8.3 million USD budget shortfall appeared alongside that slowdown. I have no direct evidence the two are linked, but two independent data clusters pointing the same way is enough for me to note it.

The report's author calls this a win for WADA. That is the author's framing, and the data beneath it is messier: audits improved on a small sample, but testing non-conformities rose; total volume rose, but the growth rate fell; net surplus is positive, but arrears from two major states account for nearly the entire shortfall.

I recall a principle learned after too many occasions of over-trusting a single indicator: correlation is not causation, and a stable series is not necessarily a safe one. A flat AAF rate across three years could be a sign of healthy stability, or of a system testing so precisely that it finds nothing more. The report does not distinguish the two. Neither do I.

The signals I will track next cycle: the growth rate of testing volume in the following report, whether the AAF rate breaks above 0.85%, and the payment status of both the United States and Russia. Together those three variables will show whether the system is expanding or eroding. For swimming, where out-of-competition testing is the real shield of fairness, the answer lies in where samples are collected, not in the total count.

The 2027 Code takes effect on January 1, 2027. That is a date every federation should prepare for in advance, not after.

Limits of the data: This analysis rests on WADA operational data, not on any individual athlete file. Factors that cannot be quantified — the political pressure behind arrears, the real quality of each audit, the motives of the parties — do not appear in the spreadsheet. Numbers have no gender, but the people who read them do. I do not trust emotion. I trust a data series longer than your emotion — but I still have to state clearly where that series stops.